NCT04291248 2020-03-02
A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown